Santa Clara-based
Cell Biosciences said late Tuesday that it has acquired
Alpha Innotech Corp in a deal worth approximately $17.9M in cash. San Leandro-based Alpha Innotech develops digital imaging systems for genomic and proteomic research, and employs 62. Cell Biosciences said that Alpha Innotech was profitable and had revenues of $17.6M in 2008. Cell Biosciences said it raised $19M in a second, Series C closing and a Series D funding for the acquisition, which was led by The Wellcome Trust, and also included Domain Associates, Novo A/S, Latterell Venture Partners, The Vertical Group, and the Royal Bank of Canada. The firm was advised by BroadOak Partners in the deal.
posted on Wednesday, September 9, 2009
Related companies:
Cell Biosciences
Related stories:
> Cell Biosciences Completes Acquisition of Alpha Innotech
> Cell Biosciences Acquires Convergent Bioscience, Raises Funding
> Cell Biosciences Gets $10M
> Cell Biosciences Gets Funding
> Cell Biosciences Acquires Canadian Firm
silicontap.com Home